Gattai, Minoli, Partners in the sale of DOC Generici to TPG

The Firm advised ICG and Merieux Equity Partners in the sale of DOC Generici, leading company in the Italian market in the distribution of generic drugs, to TPG Capital, private equity platform of the global alternative asset management firm TPG.

Following the signing of the acquisition agreements, completion of the transaction is subject to the customary regulatory authorizations.

ICG and Merieux Equity Partners have been advised by an interdisciplinary team led by partner Gerardo Gabrielli, with senior associate Carolina Gattai and associate Roberto Garrone. Advice for the finance profiles has been provided by partner Lorenzo Vernetti and senior associate Federico Tropeano, while partner Cristiano Garbarini and counsel Alban Zaimaj assisted with regard to the tax aspects of the transaction. Assistance on antitrust matters has been provided by partner Silvia D’Alberti and counsel Fabiana Campopiano, while counsel Damiano Battaglia curated golden power aspects. Finally, due diligence activities have been carried out by senior associate Clara Balboni and associates Nicola Stefani and Camilla Marzato.